Expert Ratings for Globus Medical
Portfolio Pulse from Benzinga Insights
Globus Medical (NYSE:GMED) has received various analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 3 indifferent. Over the past 3 months, 6 analysts have offered 12-month price targets for Globus Medical, with an average price target of $66.33, up by 0.5% from the previous average of $66.00.
November 08, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Globus Medical has received mixed analyst ratings, but the average price target has increased, indicating a positive outlook.
The increase in the average price target suggests that analysts have a positive outlook on Globus Medical. However, the mixed ratings indicate some uncertainty. The bullish and somewhat bullish ratings outnumber the indifferent ones, which could lead to a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100